Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001683168-22-006927
Filing Date
2022-10-17
Accepted
2022-10-17 17:02:08
Documents
3

Document Format Files

Seq Description Document Type Size
1 ADDITIONAL DEFINITIVE PROXY SOLICITING MATERIALS xenetic_defa14a.htm DEFA14A 12360
2 GRAPHIC xenetic_image1.jpg GRAPHIC 125516
3 GRAPHIC xenetic_image2.jpg GRAPHIC 102103
  Complete submission text file 0001683168-22-006927.txt   327224
Mailing Address 945 CONCORD ST. FRAMINGHAM MA 01701
Business Address 945 CONCORD ST. FRAMINGHAM MA 01701 781-778-7720
Xenetic Biosciences, Inc. (Filer) CIK: 0001534525 (see all company filings)

EIN.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37937 | Film No.: 221314212
SIC: 2834 Pharmaceutical Preparations